Study Finds Estrogen Loss After Menopause May Affect Heart Health via Gene Regulation - Video

Menopause doesn't just change hormones-it may quietly rewrite how the heart is regulated at a genetic level.

A new study from Virginia Tech scientists suggests that the rise in cardiovascular risk after menopause may be driven not only by falling estrogen, but by bigger changes in gene activity.

Published in Cells, the research highlights how declining estrogen levels can reshape the epigenome—the system that controls when genes are switched on or off. These epigenetic shifts may help explain why conditions like heart disease, diabetes, and metabolic disorders become more common in women after menopause.

For years, estrogen loss has been viewed as the primary trigger behind increased cardiovascular risk. But this study reframes the issue, showing that hormone decline may set off longer-lasting changes in gene regulation that affect multiple systems, including metabolism, inflammation, and vascular health.

The findings also suggest that commonly used treatments—such as lipid-lowering drugs, glucose-lowering medications like GLP-1 receptor agonists and SGLT2 inhibitors, and lifestyle interventions like diet and exercise—may work in part by influencing these gene-regulatory pathways. Importantly, cardiovascular disease remains the leading cause of death among women, and its risk rises sharply during the menopause transition.

While much of the current evidence comes from laboratory studies, researchers emphasize the need for more human-based research to fully understand these processes. Ongoing work is also exploring conditions like heart failure with preserved ejection fraction (HFpEF), which disproportionately affects postmenopausal women.

Ultimately, this research signals a shift in thinking—moving from a hormone-centric view to a broader understanding of how menopause reshapes the body at a molecular level, with important implications for future prevention and treatment strategies.

REFERENCE: Edwards, A., et al. (2026). Estrogen, Epigenetics, and Cardiometabolic Health: Mechanisms and Therapeutic Strategies in Postmenopausal Women. Cells. DOI: 10.3390/cells15060529. https://www.mdpi.com/2073-4409/15/6/529